Skip to content

Clinical study to evaluate the efficacy of herbal hair oil in the patient of hair fall

Clinical trial to evaluate the efficacy of polyherbal hair oil(Habbul As, Amla, Mazu, Roghan kunjad) for Intithar al-Shar (diffuse hair loss): A Single arm, interventional study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082241
Enrollment
50
Registered
2025-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L659- Nonscarring hair loss, unspecified

Interventions

Intervention1: Roghan (oil): It is a classical unani formulation taken from Al- Hawi. The formulation comprises of three single herbal drug namely Habbul As (Myrtus communis),Amla (Emblica officinalis

Sponsors

Central Council for Research In Unani Medicine CCRUM New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and female Patients of age between 18-40 years. Hair loss more than 100 strands per day. Patients who are willing to give consent and are able to follow up

Exclusion criteria

Exclusion criteria: Known cases of hypothyroidism. Patients with male androgenetic alopecia, seborrhic dermatitis, lichen planopilaris, scalp psoriasis, tinea capitis, alopecia areata, trichotillomania & scaring alopecia .Patients with surgical correction of scalp hair loss (hair transplant) Patients who fail to give written consent.

Design outcomes

Primary

MeasureTime frame
1) Hair shedding Visual Scale 2) TrichoscopyTimepoint: 2 month

Secondary

MeasureTime frame
1) Hair pull test 2) Investigator Assessment using PhotographTimepoint: 2 month

Countries

India

Contacts

Public ContactDr Sadiya Khatoon

Regional Research Institute of Unani Medicine (RRIUM), srinagar

hussainzaffar6@gmail.com7006021996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026